Cidara Therapeutics Inc. (CDTX) Declined -5.95% or -0.25 To Price $3.95 On Wednesday


Cidara Therapeutics Inc. (CDTX) declined -5.95% or -0.25 to $3.95. It is about 125786 shares traded, which is 141.12% compare to the average total volume 89134. The market cap of CDTX is $109.33 million. The year to date change is -45.52%. The 52 week price range is from $3.7 to $8.8. Price of CDTX have changed -3.45% during last week. It have changed -19.23% over last month, -2.33% over last 3 months, -41.26% over last 6 months and -40.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CDTX is 5.11. It is 29.37% above current price. The 200-day Moving Averages for CDTX is 6.14. It is 55.44% above current price. The 52-week High is 8.8. It is 122.78% from the current price. The 52-week Low is 3.7. It is -6.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CDTX is 11.29 on 2018-07-13. Short % to float is 4.24%. There are some statistics of CDTX. It is has market cap $109.33 million. The share outstanding is 27.68 million. The average volume is 89134. It has 142.16M cash and 19.68M in debt. The percent of top 15 Institution holding is 73.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CDTX is -93.11%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CDTX is -72.49%.


Tags:

Share this post